Placebo effects in Parkinson's disease clinical trials

被引：0
|
作者：
Goetz, CG
Leurgans, S
Raman, R
Stebbins, GT
机构：
来源：
NEUROLOGY | 1998年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S07005
引用
收藏
页码：A71 / A71
页数：1
相关论文
共 50 条
  • [21] Clinical research coordinator workload in clinical trials in Parkinson's disease
    Dustin, KJ
    Shulman, LM
    [J]. MOVEMENT DISORDERS, 2006, 21 : S121 - S121
  • [22] Challenges in detecting disease modification in Parkinson's disease clinical trials
    Athauda, Dilan
    Foltynie, Thomas
    [J]. PARKINSONISM & RELATED DISORDERS, 2016, 32 : 1 - 11
  • [23] Apomorphine - pharmacological properties and clinical trials in Parkinson's disease
    Jenner, Peter
    Katzenschlager, Regina
    [J]. PARKINSONISM & RELATED DISORDERS, 2016, 33 : S13 - S21
  • [24] Clinical trials aimed at detecting neuroprotection in Parkinson's disease
    Hauser, Robert A.
    Zesiewicz, Theresa A.
    [J]. NEUROLOGY, 2006, 66 (10) : S58 - S68
  • [25] Gender representation in nonsurgical clinical trials in Parkinson's disease
    Whitney, CM
    Maddux, BN
    Riley, DE
    [J]. NEUROLOGY, 2001, 56 (08) : A375 - A376
  • [26] New Clinical Trials for Nonmotor Manifestations of Parkinson's Disease
    Schrag, Anette
    Sauerbier, Anna
    Chaudhuri, Kallol Ray
    [J]. MOVEMENT DISORDERS, 2015, 30 (11) : 1490 - 1503
  • [27] The Linked Clinical Trials initiative (LCT) for Parkinson's disease
    Brundin, Patrik
    Wyse, Richard K.
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 307 - 315
  • [28] Parkinson's disease: From human genetics to clinical trials
    van der Brug, Marcel P.
    Singleton, Andrew
    Gasser, Thomas
    Lewis, Patrick A.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (305)
  • [29] Patterns of outcome measurement in Parkinson's disease clinical trials
    Mitchell, SL
    Harper, DW
    Lau, A
    Bhalla, R
    [J]. NEUROEPIDEMIOLOGY, 2000, 19 (02) : 100 - 108
  • [30] Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease
    Arnulf, I.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S204 - S204
12345